- $1.02bn
- $681.23m
- SG$658.35m
- 97
- 76
- 88
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 6-K |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 330 | 435 | 555 | 664 | 658 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 249 | 327 | 423 | 522 | 512 |
Operating Profit | 81.1 | 107 | 132 | 142 | 146 |
Net Income Before Taxes | 81.1 | 107 | 132 | 142 | 146 |
Provision for Income Taxes | |||||
Net Income After Taxes | 73.5 | 86.1 | 104 | 105 | 120 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 73.5 | 86.1 | 104 | 105 | 120 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 73.5 | 86.1 | 104 | 105 | 120 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.515 | 0.569 | 0.777 | 0.707 | 0.839 |